European Commission restructures health and consumers department
This article was originally published in RAJ Devices
DG SANCO, the European Commission's Health and Consumers Directorate General, is being restructured partly in an attempt to make the department better able to help facilitate the introduction of innovative solutions in the area of health. The changes, which involve the creation of a new directorate and a new advisory post on innovation reporting directly to the head of DG SANCO, will result in public health issues being managed separately from health systems and products1,2.
You may also be interested in...
Where are the biggest challenges for notified bodies and manufacturers now there is some experience with the MDR, and can the sector manage the new regulatory requirements successfully?
The European Commission has finally published detailed guidance on the EU IVDR’s classification rules. The IVDR’s completely new classification regime means guidance is urgently needed.
Do you know how to avoid the pitfalls when it comes to clinical evidence under the MDR? Or whether evidence gathered outside the US counts? Amie Smirthwaite of Maetrics answers these and other pivotal questions in this third and final part of an interview series with Medtech Insight.